Ads
related to: what is daratumumab used for treatment- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- About DARZALEX®
Learn About a Treatment Method and
How DARZALEX® Works
- Read Patient Stories
Learn About the Treatment Journey
From Real Patients & Caregivers
- Important Safety Info
Learn About Important Safety
Information for DARZALEX®
- Sign Up for Support
Register With Janssen CarePath to
Receive Support Program Information
- DARZALEX® Side Effects
Search results
Results From The WOW.Com Content Network
Treatment of multiple myeloma with daratumumab potentially increases the patient's susceptibility to bacterial and viral infections, due to the killing of natural killer cells (which are the main innate immune system defense against virus). [16] Daratumumab frequently causes human cytomegalovirus (CMV) reactivation by an unknown mechanism. [17]
It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]
When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source , are explained in Nomenclature of monoclonal antibodies .
After daratumumab treatment, both patients showed stabilization of kidney function parameters and a steep decline in dd-cfDNA levels below the clinical threshold for rejection. Biopsies six months after treatment demonstrated complete histologic resolution of AMR activity in one patient and partial resolution in the other.
The report also revealed that more than half of U.S. adults (57%) have type 2 diabetes or prediabetes. "Although we have made a lot of progress against cardiovascular disease in the past few ...
CD38 inhibitors may be used as therapeutics for the treatment of asthma. [30] CD38 has been used as a prognostic marker in leukemia. [31] Daratumumab (Darzalex) which targets CD38 has been used in treating multiple myeloma. [32] [33]
Ads
related to: what is daratumumab used for treatment